<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02680769</url>
  </required_header>
  <id_info>
    <org_study_id>3577</org_study_id>
    <nct_id>NCT02680769</nct_id>
  </id_info>
  <brief_title>Effect of Magnesium Supplementation in COPD</brief_title>
  <official_title>Daily Supplementation of Magnesium Citrate in Moderate-severe Chronic Obstructive Pulmonary Disease: a Randomized, Controlled, Double-blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Magnesium (Mg) is involved in several pathways that could be affected in chronic obstructive
      pulmonary diseases (COPDs), namely in the contractility and excitability of neuro-muscolar
      endothelial cells and low-grade inflammation, a typical state of COPD. In this sense, several
      randomized controlled trials (RCTs) confirmed a positive role of Mg in asthma since
      long-period oral supplementation of Mg leads to a clinical and spirometric improvement.

      Subjects with COPD seem to have a reduced bioavailability of Mg probably due to the use of
      drugs that may increase Mg losses (e.g. beta-agonists and cortisones), to a reduced dietary
      Mg intake, and heavy smoking. A recent study showed that the administration of endovenous or
      aerosol Mg sulphate with beta-agonists acutely improve maximum expiratory flow during COPD
      relapses as well as the prolonged treatment with endovenous sulphate Mg led to a reduction in
      pulmonary hyperinflation and increase in muscles involved in respiration, with a consequent
      clinical and instrumental improvement.

      These evidences suggest that a chronic supplementation with Mg could improve COPD in clinical
      and instrumental parameters, but, at the best of our knowledge, no study was available in
      this sense.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in forced expiratory volume in the 1st second between baseline and 6 months</measure>
    <time_frame>0-3-6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>300 mg of citrate Mg/daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>300 mg of citrate Mg</intervention_name>
    <description>This group will take an oral supplementation of 300 mg of citrate magnesium</description>
    <arm_group_label>Magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>This group will take a placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (&gt;18 years).

          -  Moderate-severe COPD (FEV1 between 30-80% of theorical values).

        Exclusion Criteria:

          -  Already taking magnesium or calcium supplementations.

          -  Severe renal (creatinine clearance&lt; 30 ml/min) or hepatic decline or presence of other
             co-morbidities interfering with outcomes (e.g. dementia).

          -  Hypermagnesemia (serum Mg&gt;1.85 mmol/L).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Sergi, MD</last_name>
    <phone>00390498218492</phone>
    <email>giuseppe.sergi@unipd.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Padova-Geriatrics Section</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Veronese, MD</last_name>
      <phone>00390498218492</phone>
      <email>ilmannato@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Gontijo-Amaral C, Ribeiro MA, Gontijo LS, Condino-Neto A, Ribeiro JD. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. Eur J Clin Nutr. 2007 Jan;61(1):54-60. Epub 2006 Jun 21.</citation>
    <PMID>16788707</PMID>
  </reference>
  <results_reference>
    <citation>Beasley R, Aldington S. Magnesium in the treatment of asthma. Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):107-10. Review.</citation>
    <PMID>17218820</PMID>
  </results_reference>
  <results_reference>
    <citation>Aziz HS, Blamoun AI, Shubair MK, Ismail MM, DeBari VA, Khan MA. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. Ann Clin Lab Sci. 2005 Autumn;35(4):423-7.</citation>
    <PMID>16254259</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2016</study_first_submitted>
  <study_first_submitted_qc>February 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2016</study_first_posted>
  <last_update_submitted>June 10, 2016</last_update_submitted>
  <last_update_submitted_qc>June 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

